Polyvalent Cation-Containing Products has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Cabotegravir Sodium, Dolutegravir Sodium And Rilpivirine Hydrochloride. Patients taking Polyvalent Cation-Containing Products should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 2
Moderate: 2

Moderate (2)

Polyvalent Cation-Containing Products + Cabotegravir Sodium— Coadministration may lead to decreased absorption of cabotegravir.
Polyvalent Cation-Containing Products + Dolutegravir Sodium And Rilpivirine Hydrochloride— Polyvalent cations may decrease dolutegravir absorption. Separate administration or consider alternatives.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.